kalshi
Science and Technology
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?
before November
64%
implied YES probability
Price history
Last 2 days ·
High 69% ·
Low 68%
Other outcomes in this event
Related stocks
Trade on Kalshi
Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate
public order-book and trading data for analysis.
Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.